Valuation: Caplin Point Laboratories Limited

Market Cap 194B 2.03B 1.78B 1.63B 1.52B 2.89B 2.93B 19.65B 7.61B 94.97B 7.64B 7.47B 327B P/E 2026
17.9x
P/E 2027 * 27.2x
Enterprise Value 194B 2.03B 1.78B 1.63B 1.52B 2.89B 2.93B 19.65B 7.61B 94.97B 7.64B 7.47B 327B EV / Sales 2026
5.23x
EV / Sales 2027 * 7.78x
Free-Float
26.39%
Yield 2026 *
-
Yield 2027 * 0.16%
1 day-0.58%
1 week+1.15%
Current month-2.93%
1 month+27.59%
3 months+61.86%
6 months+41.68%
Current year+38.34%
1 week 2,486.8
Extreme 2486.8
2,680
1 month 1,954.2
Extreme 1954.2
2,680
Current year 1,502.45
Extreme 1502.45
2,680
1 year 1,502.45
Extreme 1502.45
2,680
3 years 782.35
Extreme 782.35
2,680
5 years 575
Extreme 575
2,680
10 years 180
Extreme 180
2,680
Manager TitleAgeSince
Chief Executive Officer 71 2015-03-27
Director of Finance/CFO - 2016-02-18
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 73 2010-01-26
Director/Board Member - 2025-11-04
Director/Board Member 71 2015-03-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.58%+1.15%+27.43%+215.89% 2.05B
+0.26%-0.18%+12.22%+77.92% 47.1B
+8.72%+6.67%+69.77%+119.98% 34.57B
-0.05%+1.26%-3.94%+43.46% 12.38B
-0.85%+0.05%+9.71%+88.63% 11.64B
+0.78%-1.91%+33.16%+121.55% 8.87B
-0.08%-0.25%+22.32%+44.60% 7.1B
+1.44%+2.21%+56.02%-7.83% 6.85B
+1.58%+0.71%+25.18%+224.85% 6.42B
+6.55%+16.01%-27.50%+16.83% 5.61B
Average +1.78%+2.15%+22.44%+94.59% 14.26B
Weighted average by Cap. +2.56%+0.36%+27.72%+89.13%

Financials

2026 2027 *
Net sales 21.28B 224M 195M 179M 167M 317M 322M 2.16B 837M 10.44B 839M 821M 35.96B 24.88B 261M 228M 210M 196M 371M 377M 2.52B 978M 12.2B 981M 960M 42.05B
Net income 6.16B 64.73M 56.56M 51.94M 48.43M 91.82M 93.37M 625M 242M 3.02B 243M 238M 10.41B 7.13B 74.87M 65.42M 60.07M 56.02M 106M 108M 723M 280M 3.5B 281M 275M 12.05B
Net Debt - -
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
3,966
Date Price Change Volume
26-07-02 2,547.20 -0.58% 8,483
26-07-01 ₹2,562.15 -2.36% 8,497
26-06-30 ₹2,624.15 +2.57% 40,264
26-06-29 ₹2,558.40 +2.04% 20,602
26-06-25 ₹2,507.25 -0.44% 2,924
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,547.20INR
Average target price
2,505.00INR
Spread / Average Target
-1.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAPLIPOINT Stock